TypeOnline Course
Student Enrolled5
(1 ratings)
Price$1200 / Rs. 46000$840 USD / 36800 INR.
Buy NowBook Now

Admission Process

Sign in or create account at www.nckpharma.com with all details and make the course fees payment to start the course

Sign Up Now

Pharmaceutical Global Business Course


Course Description

Course Objective

Course duration




Course Deliverable

Add on Certification

Executive Program in Pharmaceutical Global Business is conceptualized with vision to enhance competency of middle and middle / top level managers who are working in pharmaceutical, bio-pharmaceuticals industry. This course ideally developed for the working professionals of pharmaceutical and biopharmaceutical industry.

Course Code: KPE-C-024

Course Title: KPE’s Advance Diploma in Pharmaceutical Global Business

Course Type: Online Course

Course Description

Unlike other management business courses that concentrate narrowly on a diverse function or piece of the business—accounting, finance, marketing, production, human resources, or information systems, strategic management is a big picture course.
This course focus on the real life working on the whole spectrum of pharmaceutical and bio-pharmaceutical strategic business and management. The centre of attention is the total pharma and biopharma enterprise–-the industry and competitive environment in which it operates, its long-term direction and strategy, its resources and competitive capabilities, and its prospects for success. pharma global business online course
Throughout the course, the spotlight will be trained on the foremost issue in running a pharmaceutical and biopharmaceutical business enterprise: “What must managers do, and do well, to make the pharmaceutical company a winner in the game of business?”
The answer that emerges, and which becomes the theme of the course, is that good strategy-making and good strategy-execution are the key ingredients of company success and the most reliable signs of good management. The mission of the course is to explore why good strategic management leads to good business performance, to present the basic concepts and tools of strategic analysis, and to drill you in the methods of crafting a well-conceived strategy and executing it competently. You’ll be called on to probe, question, and evaluate all aspects of a company’s external and internal strategic situation. You’ll grapple with sizing up a company’s standing in the marketplace and its ability to go head-to-head with rivals, learn to tell the difference between winning strategies and mediocre strategies, and become more skilled in spotting ways to improve a company’s strategy or its execution. In the midst of all this, another purpose is accomplished: to help you synthesize what you have learned in prior business courses. Dealing with the grand sweep of how to manage all the pieces of a business makes strategic management an integrative, KPE’s Executive Program in Pharmaceutical Global Business course in which you’ll see how the various pieces of the business puzzle fit together and why the different parts of a business need to be managed in strategic harmony for the organization to operate in winning fashion.

Objective of the course

• To develop your capacity to think strategically about a pharmaceutical and Biologic company, its present business position, its long-term direction, its resources and competitive capabilities, the caliber of its strategy, and its opportunities for gaining sustainable competitive advantage.

• To develop clear cut understanding on drug discovery to development to commercialization process effectively, to strategise the pharmaceutical business in regulated, semi-regulated and unregulated market. 

• To build your skills in conducting branding activities and strategic analysis in a variety of competitive situations and, especially, to provide you with a stronger understanding of the competitive challenges of a global pharmaceutical environment.

• To give you hands-on experience in crafting pharmaceutical branding, business strategy, reasoning carefully about strategic options, using what-if analysis to evaluate action alternatives, and making sound strategic decisions.

• To acquaint you with the managerial tasks associated with implementing and executing company growth strategies, drill you in the range of actions managers can take to promote competent strategy execution, and give you some confidence in being able to function effectively as part of a company’s strategy-implementing team.

• To develop your powers of pharmaceutical managerial judgment, help you learn how to assess business risk, and improve your ability to make sound decisions and achieve effective outcomes.

Course Duration

1 Year from the date of admission.

Features of the course

  • 24×7 online access – learn at your convenience.
  • Orientation to job related practical aspects of different domain of the pharmaceutical and biopharmaceutical operations.
  • Simulation to real life working to enhance the practical skills.
  • Access to Industry Databank.
  • Access to 1000’s of Pharmaceutical Case Studies.
  • Attend Lectures of all different chapters / study content.

Minimum qualification Graduation in any discipline with more than 60 months (5 Years)  of work experience in middle and top management. Work Experience is mentioned is mandatory for admission into this course. Work Experience certificate / proof need to be provided at the time of admission.


Frequently asked questions

Read FAQs


  • Upon completion of the admission process, 34 Modules  in the form of printable e-book will be available for download. All books can be downloaded by visiting your dashboard.
  • Immediately upon admission, course participant will be provided with user id and password to access personalized web page through which he can access e-lectures, cases studies, etc. across from anywhere using internet.
  • While attending lectures, you can also download the lecture handout and save in your system.

  • The participants of Global Business Registrant will get two add on certification.
  • Participant can choose add on courses of any 1 month or 1 week certification course.
  • There will be no fees  for add on courses and courses can be opted any time during the Global Business Course access period.
  • On completion of add on course, participant will be issuing course certificate.
  • You can activate this add on course anytime during the active 1 year course tenure.

Course Syllabus & Orientation:

Section 1Global Pharmaceutical R&D: Discovery to Development
Lecture 1Drug Regulation Fundamentals
Lecture 2Investigational New Drug Application (INDA)
Lecture 3New Drug Application (NDA)
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA) Filing
Lecture 6Review on Drug Discovery and Development
Lecture 7Generic Drug User Fees Act (GDUFA)
Lecture 8Prescription Drug User Fees Act (PDUFA)
Lecture 9Handling of orange book
Lecture 10USFDA expedited programs
Lecture 11Practical Training on INDA, NDA, ANDA filing
Lecture 12505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 13Authorized Generics: Key Understanding
Lecture 14Exploratory IND Vs. Traditional IND
Lecture 15Patents Vs. exclusivity
Lecture 16Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 17Orphan Drug & Orphan Drug Act
Lecture 18Clinical Research : Detailed Understanding
Lecture 19Clinical Trial Protocol Writing
Lecture 20Ethics in Clinical Research
Lecture 21FDA Forms and How to fill the resources
Lecture 22Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !
Lecture 23Advance Learning on 505B2 Pathway
Lecture 24Importance and Significance of Phase 2b Clinical Trial 
Lecture 25Informed Consent | Practical Training on Preparing ICF | Templates
Section 2Innovation Management in Pharmaceutical & Biopharmaceutical Industry
Lecture 26USPTO - Introduction
Lecture 27Patent
Lecture 28Patent - Practical on search and filing - USPTO
Lecture 29Trademark - Practical on TM Search & Registration Process - USPTO
Lecture 30Trademark - Practical on TM Search USPTO
Lecture 31Trademark Search assignment USPTO
Lecture 32Patent - Practical on search and filing in Indian Patent Office
Lecture 33Trademark - Practical on TM Search & Registration Process in India
Lecture 34Fundamental Understanding of Patent, Trademark Licensing and related terminology
Lecture 35Patent Cliff
Section 3Global Strategic Management
Lecture 36Understanding of Regulatory Strategies
Lecture 37Advance study on Para IV Filing
Lecture 38Para IV Notices
Lecture 39Evergreening - Patent Life Extension Strategies
Lecture 40Pay For Delay Strategy
Lecture 41REMS Strategic Planning 
Lecture 42Compulsory Licensing
Lecture 43Licensing & Technology Transfer
Lecture 44In-Licensing Vs. Outlicensing
Lecture 45LOE Strategies for Innovator Brands with case study
Lecture 46Paediatric Exclusivity and Paediatric Study Plan Development
Lecture 47Drug Repurposing
Lecture 48Licensing - Advance Learning 
Lecture 49Detailed Understanding on 505(b)(2) VS. Suitability Petition : Case Based Learning
Lecture 50NCE Vs. 505b2 application - Case Based Learning 
Lecture 51FTF - 180 Days Exclusivity - Case Based Learning
Lecture 52Classic case study of the 505b2 filing : Case Based Learning
Lecture 53Strategic Planning in Combating 30 months stay strategies of innovator company- Case Based Learning
Lecture 54Pipeline in a Molecule
Lecture 55Emergency Use Authorization (EUA)
Section 4Basic Fundamental of Pharma Production & Plant Management
Lecture 56Definition of GMP
Lecture 57Premises & Plant Layout Designing
Lecture 58Sanitation and Hygiene
Lecture 59Equipment Modules
Lecture 60Production Modules
Lecture 61Documentation
Lecture 62Quality Control
Lecture 63G7 Lecture Product Complaint
Lecture 64G8 Lecture Storage Module
Lecture 65ISO and ISO Audits
Lecture 66Pharmaceutical SOPs Management from regulatory perspective
Lecture 67SOP Automation in Pharmaceutical Industry
Lecture 68USFDA warning Letter & CAPA
Lecture 69USFDA Warning Letter
Lecture 70Detailed Understanding of DMF & SMF
Section 5Global Business : European Union - Regulatory & Strategic Planning
Lecture 71Introduction to EU Regulation 
Lecture 72Orientation to European Countries and National Regulatory Bodies
Lecture 73Orientation to European Countries and National Regulatory Bodies
Lecture 74Overview of EU Regulation
Lecture 75EMA and EMA Authorisation Process
Lecture 76Summary of Product Characteristics
Lecture 77Compassionate Use
Lecture 78EU MA Strategic Planning: Full, Full-mixed, hybrid applications. Generic, Similar biologic application pathway, Well-established use application, Fixed combination application, Informed consent application
Lecture 79Validity of the EU MA  - Renewal steps, Cessation of the marketing authorisation, Significance of "Placed in Union Market", Suspension or withdrawal & EU MA for licensed products
Lecture 80Data Exclusivity and Market Protection - Supplementary Patent Protection, Exclusivity, 6/10 Rule, 8+2+1 Formulae
Lecture 81EU Orphan Medicinal Products Regulation
Lecture 82Conditional marketing authorisation | Marketing authorisation under exceptional circumstances
Lecture 83Paediatric use marketing authorisation (PUMA) & Paediatric Investigation Plan (PIP)
Lecture 84Summary of Product Characteristics 
Lecture 85Compassionate Use
Lecture 86MHRA - UK Regulation 
Lecture 87The 'sunset clause' for marketing authorisation of pharmaceuticals
Lecture 88EU variation - Types, Requirement & Planning - IA, IAIN, IB, II ; US FDA Variation AR, CBE-0, CBE-30, PAS - Strategic Discussion | Similarities & Differentiation
Lecture 89EU Prime Designation 
Lecture 90Accelerated assessment by EMEA
Lecture 91EU Adaptive Pathway
Lecture 92European public assessment report (EPAR) - Importance, Component, Management, Updation 
Lecture 93SPOR  - Concept of Master Data Management  
Section 6Biopharmaceutical - Regulatory and Strategic Management
Lecture 94Introduction : Biopharmaceuticals
Lecture 95Classification of Biopharmaceutical 
Lecture 96Introduction to Biosimilar 
Lecture 97Chemical Drugs Vs. Biologic Drugs
Lecture 98Principle of Naming of Biologics
Lecture 99Current Trends in Biopharmaceutical Market
Lecture 100Global Biologics Market – By Product
Lecture 101Market Share of Different Class of Biopharmaceuticals
Lecture 102Blockbuster Biologic - Classifications,  Indications, Global Sales
Lecture 103Market Understanding: Leading Biosimilar Companies
Lecture 104Market Understanding: Top Leading Brands
Lecture 105Recombinant protein
Lecture 106Monoclonal Antibodies Vs. Polyclonal Antibodies
Lecture 107Monoclonal Antibodies
Lecture 108Synthetic Immunomodulators
Lecture 109Production of Monoclonal Antibodies
Lecture 110Cytokines
Lecture 111Interferon
Lecture 112Erythropoiesis-stimulating agent
Lecture 113Biological Licensing Application (BLA)  | 351(a) application | Form 356h | Differentiation with NDA | Timeline | Handling FDA queries
Lecture 114Abbreviated Biosimilar Application - 351(k): Advance Strategic Planning Process : Originator Vs. Biosimilar Development and Regulatory Approval Process | Reference Biologic | Purple Book | Data Requirements
Lecture 115Purple Book: Significance | Searching | Assignments
Lecture 116Biosimilar Development Process
Lecture 117Strategic Consideration for Biosimilar Development 
Lecture 118Bio-Manufacturing Process Information
Lecture 119Studies required for approval of biosimilar
Section 7Drug Registration Dossier
Lecture 120MA Submission Dossier Management
Lecture 121CMC Dossier & Compliance Management
Lecture 122Introduction to Electronic Common Technical Document (ECTD)
Lecture 123Advance Practical Training on Dossier Preparation focusing on drug registration in export countries
Lecture 124Modules on Stability Study 1
Lecture 125Importance of effective dossier management
Lecture 126Certificate of Analysis
Lecture 127Detailed Understanding on ANDA Submission Dossier 
Lecture 128Prior Approval Submission 
Lecture 129Detailed Understanding on ANDA Fees
Lecture 130Discussion on 85 common deficiency in CTD submission dossier
Lecture 131Key Consideration for Drug Master File Preparation and Submission 
Lecture 132Practical Understanding on Drug Master File Preparation and Submission
Lecture 133Associated Learning: Site Master File - Detailed Understanding 
Lecture 134DMF Completeness Assessment
Lecture 135Drug Master File - Fees
Lecture 136Drug Master File - Global Perspective [Across Different Regions]
Section 8Plant Inspection and Audit Handling
Lecture 137Data Integrity issues in Pharmaceutical Industry
Lecture 138Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter 
Lecture 139CAPA
Section 9Introduction to Pharma Brand Manager
Lecture 140Pharma Product Management
Lecture 141Detailed Understanding of Product Management Job
Lecture 142Classification of Doctors
Section 10Marketing Orientation for Business Manager
Lecture 143Marketing Orientation for Product Manager
Lecture 144Why Is Market Research Important in Pharmaceutical Business?
Lecture 145Product Life cycle 
Lecture 146Advance - Strategic Planning in Product Life cycle Management
Lecture 147Segmentation
Lecture 148Pricing
Lecture 149Distribution Channel in Pharmaceutical Industry 
Lecture 150A Pharmaceutical Segmentation outlook
Lecture 151Promotion in Pharmaceutical Industry : Communication Model, Effective promotional communication, Push Vs. Pull Strategy and Buying Decision Process
Lecture 152Practical understanding on Prescription Accelerating Materials used in pharmaceutical promotion
Lecture 153Setting and Quantifying Promotional Objectives
Lecture 154Break even analysis
Lecture 155Method of Promotional Budgeting
Lecture 156Basics of Advertising
Lecture 157The Advertising agency
Lecture 158Brand Recall | Brand Recognition |Top of mind - How to calculate brand recall value?
Lecture 159Advertising Planning - ATL, BTL, TTL activities
Lecture 160Target Audiences for Pharma Promotion : Types and Specialization
Lecture 161Business segments of Pharmaceutical Companies
Lecture 162Target Audience Selection Based on Products
Section 11Practical Training on Pharma Brand Logo Development
Lecture 163Brand Logo - Introduction
Lecture 164Purpose of Brand Logo
Lecture 165Component of Brand Logo
Lecture 166Trademark Registration
Lecture 167Trademark - Practical on TM Search
Lecture 168Trademark Search assignment
Lecture 169How to design excellent brand logo?
Lecture 170How to design excellent brand logo?
Lecture 171Color Systems - RGB & CMYK
Lecture 172Few Case Studies related to brand names and logos
Lecture 173Brand Logo - Simulation
Lecture 174Colour Trademarking in Pharma Branding
Lecture 175How to protect pharma brands globally?
Lecture 176Rebranding in Pharmaceuticals
Lecture 177Brand Logo Development: Real Life Simulation
Lecture 178Brand Tagline - Punchline
Lecture 179Pharma Brand Name Generator
Section 12Advance Pharma Brand Management - 1
Lecture 180Fundamental of Pharma Marketing Plan 
Lecture 181Basic Understanding how to launch a pharmaceutical product into the market 
Lecture 182Practical Training on Marketing Plan Preparation with real life example
Lecture 183Marketing Campaign Development : Importance of Target Audience Segmentation for effective targeting 
Lecture 184New Product Launch Framework
Lecture 185Sectional Development of Marketing Plan
Lecture 186Decide about brand USP -What to promote 
Lecture 187Sample Marketing Plan : Febuxostat
Lecture 188How to prepare promotogram. Download sample Promotogram
Lecture 189Importance and Handling of Cycle Meeting and its importance 
Lecture 190Brand Launch Case Study
Lecture 191Aristada - Launch Case Study
Lecture 192CSR Campaign
Lecture 193Cost Based Working for Sample Allocation
Lecture 194Increase the brand reach with advance segmentation
Lecture 195Concept of uniform branding for better brand acceptability
Lecture 196Concept of Brand Differentiation
Lecture 197Brand Plan to Marketing Campaign - Objective setting to effective execution
Section 13Advance Pharma Brand Management - 2
Lecture 198Importance of Visual Aid in Pharmaceutical Industry
Lecture 199Fundamentals of preparing visual aid
Lecture 200Indications for Drugs: Approved vs. Non-approved
Lecture 201Case Study : Indication approval to extend the usage of the brands (molecule)
Lecture 202Step by step visual aid development process
Lecture 203 Guideline of Visual Aid Designing
Lecture 204Practical Sample to understand visual aid contents and effective placement of the texts
Lecture 206Detailing and e-detailing
Lecture 207Visual Aid Development Process Review
Lecture 208Visual Aid, Literature reference Sample
Lecture 209Conference Management
Lecture 210Artwork Development Process in PMT Department
Lecture 211Product List and Reminder card development
Lecture 212Catch Cover Development
Lecture 213Packaging Development 
Lecture 214Prescribing Information and Patient Information Leaflet development
Lecture 215Types of Container for primary packaging 
Section 14Digital Pharma Marketing
Lecture 216Pharma Packaging Case Studies
Lecture 217Inbound and outbound marketing in pharma | Types of inbound and outbound marketing 
Lecture 218Digital Media Marketing Macro-Environment Analysis | Mapping of online market place | Internet marketing conversion process | Conversion Process Digital VS. Traditional | Publisher revenue model | Affiliate revenue model
Lecture 219Digital Media Marketing Micro - Environment Analysis | Web server | Web browser | http vs. https - Significance and hands on understanding | Privacy and ethical issues in internet marketing
Lecture 220Digital marketing strategy development | Planning process | E-Marketing Plan | Planning for MNC Vs. Start Up | Strategic Outcome measurement
Lecture 221Relationship marketing using digital platform | CRM | Concept of permission marketing | User Satisfaction and loyalty management | Feedback mechanism
Lecture 222Campaign planning for digital media | Goal setting | Tracking | Campaign insight | Segmentation and targeting | Message Development | Media Mix Selection | Media scheduling | Practical understanding to campaign performance matrics | CPC | CPA | PPC | ROI | CPS
Lecture 223Search Engine Optimization | Search Engine Marketing | Social Media Marketing
Lecture 224Web Analytics - Tool and Implementation 
Lecture 225Web Host - Check the hosting details 
Lecture 226Page Speed- importance and practical understanding | Check the web speed 
Lecture 227Keyword | Keyword Planning for SEO and SEM | Keyword Planner
Lecture 228Mobile Responsive | Tracking the Site 
Lecture 229HCP sites and Patient Site
Lecture 230Google Ad - Practical Training on Campaign Development and Execution
Lecture 231Digital Marketing Strategies for innovator brand | Pre launch - comuing soon, DSE Marketing | Launch activities - Day of approval (DOA) site | FDA Compliance | FDA 2253 Filing
Lecture 232Brand Portal Development
Lecture 233Relationship Marketing : KOL Management and Patient Advocacy Group 
Lecture 234Public Relation - PR firm | PR Campaign | Press Release | Technical understanding of press release writing | Digital Press Release
Lecture 235Developing Ad - Pharmaceutical Prescription, OTC Vs FMCG Brands
Lecture 236Difference between FMCG and OTC Brand Ad
Lecture 237Digital Marketing Techniques
Lecture 238Video Marketing
Lecture 239Video Marketing Techniques For Small Business Owners
Lecture 240Promoting Brand through Article Advertising and Marketing
Section 15Analytics
Lecture 241Moving annual total (MAT)
Lecture 242Compound Annual Growth Rate (CAGR)
Lecture 243Analytical Approach in Determining Brand Potential with case study
Section 16Fundamental understanding in Finance
Section 17Project & Portfolio Management
Lecture 245Introduction: Project Management
Lecture 246Difference between Project and Program
Lecture 247Program/Project Leadership versus Stage
Lecture 248Project Management Constraint
Lecture 249Key to Project Success
Lecture 250PERT, CPM, Critical Path, Project Diagram and its components
Lecture 251Qualities of a Good Project Leader
Lecture 252Qualities of a Good Team Representative
Lecture 253Project Tracking in Drug Discovery Projects
Lecture 254Project Benchmarking through a Consortium
Lecture 255Cycle Times (Stage or phase lengths)
Lecture 256he proof of concept (POC) milestone in pharma Drug Development Projects
Lecture 257What is a milestone chart?
Lecture 258Project Termination and Project Reinitiation
Lecture 259Asset Tracking
Lecture 260Levels of Project and Portfolio Management
Lecture 261Functions of Portfolio Management Team
Lecture 262Importance of Periodic Portfolio Reviews
Lecture 263Portfolio Prioritization
Section 18Business Development Skill Training
Lecture 264Pharma BusiBusiness Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets
Lecture 265Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department 
Lecture 266Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT
Lecture 267Profiling and Searching | Objectives | Search Database | Creating Opportunity Anatomy for deal analysis | Mind Mapping | Searching Tools and Techniques - Web Search | Conference | Confidentaility - CDA | MTA
Lecture 268Numerical SWOT Practical training
Lecture 269Modelling and Deal Valuation - Top Down Model | Epidemiology data method | Complex Model | Forecasting | Heuristic or ‘prophesy’ method | Different value perspectives | Deal Structuring Structuring the deal
Lecture 270Market Size Determination - Market Share | Relative Market Share | Total Vs. Actual Vs. Penetrated Market
Lecture 271Forecasting : Tools and Techniques
Lecture 272Market Sizing & Forecasting Case Study
Lecture 273Royalty Management - Royalty structuring | Royalty Calculation Method| Tiered Royalties | Terms | Royalty Reductions | Royalty Stacking - Concept and Calculation | Minimum Annual Royalties | Reach through royalties
Lecture 274Average Royalty Rates
Lecture 275Factor affecting the Royalty Rate in Pharmaceutical and Biopharmaceutical Deal
Lecture 276Distribution Licensing | Geography | Indication Splitting | Execlusive and Non-Exclusive Licensing | Sub Licenses
Lecture 277Acquisition in Pharma  | Product Acquisition| Company Acquisitions| Steps in acquisition | Financing acquisition deals | Trademark Assignment Process
Lecture 278Join Ventures in Pharmaceutical and Biopharmaceutical Industry
Lecture 280Indication Splitting | Concept | Implementation feasibility analysis 
Lecture 281Types of Deals from Discovery to Commerialication
Lecture 282Review: What are the fundamental areas of business development
Lecture 283Licensing Term Sheet | Content Structuring | Sample Term Sheet
Lecture 284Licensing Payment Scheduling: Different Types
Lecture 285Valuation Methods: DCF | rNPV | Sunk Cost Method | Comparables | Sum of Parts | Deterministic Vs. Probabilistic rNPV |  Peak Sales - Max-Min Approach
Lecture 286Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation
Lecture 287Negotiation Skill Training for Business Development and Strategic Management Professionals
Lecture 288Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model
Lecture 289Licensing Agreement : Confidentiality Agreement | MTA | A deed of Assignment | Exclusive | Non-Exclusive License | Sole License | Components - Terms - Duration - Key Considerations
Lecture 290Step By Step Implementation of Licensing Deal by Business Development Team 
Lecture 291Due Diligence Activities in Pharmaceutical Licensing
Lecture 292Pharma Business Development - Competency Test. Check your competency
Lecture 293Co-promotion & Co-marketing strategy in pharma industry 
Lecture 294Concept of Reverse co-promotion in pharma industry
Lecture 295Importance of Publications in Pharmaceutical Industry 
Lecture 296Juxtapid Case Study 
Lecture 297New Indication Approval Process and Promotion
Section 19GCC - Pharma Business
Lecture 298GCC Pharma Market
Lecture 299Export to GCC Market
Lecture 300Drug Registration in Saudi Arabia
Lecture 301Drug Registration in UAE
Lecture 302Drug Registration in Kuwait
Lecture 303Drug Registration in Bahrain
Lecture 304Drug Registration in Oman
Lecture 305Documentation Required for the GCC countries 
Lecture 306Comparison of the GCC Registration Requirement with other Regulatory Agencies
Section 20Pharma Business Africa
Lecture 307African Continent Overview
Lecture 308African Pharma Market
Lecture 309Drug Registration - African medicines regulatory
Lecture 310Basic Export Requirement for African Countries
Lecture 311Export Documentations & Important Concepts
Lecture 312Nigeria  - Drug Registration
Lecture 313Drug Registration in Algeria
Lecture 314Drug Registration in Ethiopia
Lecture 315Drug Registration in Kenya
Lecture 316Drug Registration in Egypt
Lecture 317Drug Registration in Ghana
Lecture 318Drug Registration in Botswana
Lecture 319Drug Registration in Uganda
Section 21Latam Pharma Market
Lecture 320Introduction to Latam 
Lecture 321Drug Registration and Regulation in Argentina 
Lecture 322Drug Registration and Regulation in Bolivia
Lecture 323Drug Registration and Regulation in Brazil 
Lecture 324Drug Registration and Regulation in CHILE
Lecture 325Drug Registration and Regulation in Colombia
Lecture 326Drug Registration and Regulation in Mexico
Section 22ASEAN
Lecture 327ASEAN Drug Regulatory Affairs
Lecture 328Asean Geography 
Lecture 329Drug Registration in Brunei 
Lecture 330Drug Registration in Malaysia 
Lecture 331Drug Registration in Cambodia 
Lecture 332Drug Registration in Mayanmar 
Lecture 333Drug Registration in Philippines 
Lecture 334Drug Registration in Singapore 
Section 23Other Country and Business Regioans
Lecture 335Japan
Lecture 336India
Lecture 337China | ***Updated July 2020 DRR & DMR regulation
Lecture 338Australlia
Lecture 339Russsia